Abstract
Human chitinolytic enzyme named “chitotriosidase” takes part in the defense mechanism against pathogens and the homeostasis of innate immunity. Chitotriosidase was firstly reported to be markedly high in plasma of patients with Gaucher disease. Abnormal lipid laden macrophages are thought to be responsible for stimulating the secretion of chitotriosidase in Gaucher disease. Subsequently, various disorders have also been found to be associated with elevated levels of chitotriosidase. Chronic liver diseases that are also related with macrophage activation may have elevated chitotriosidase activity. We report the second case of the literature with glycogen storage disease (GSD) type IV that presented with high chitotriosidase levels. GSD type IV should be taken into consideration in case of elevated chitotriosidase levels, stigmas of chronic liver disease, and inconsistency of lysosomal storage diseases.
Competing interests: None declared
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- GSD:
-
Glycogen storage disease
- LSD:
-
Lysosomal storage disease
- NPD:
-
Niemann-Pick disease
- PAS:
-
Periodic acid-Schiff
References
Altarescu G, Rudensky B, Abrahamov A et al (2002) Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol 71:7–10
Eide KB, Lindbom AR, Eijsink VG, Norberg AL, Sorlie M (2013) Analysis of productive binding modes in the human chitotriosidase. FEBS Lett 587:3508–3513
Escobar LF, Wagner S, Tucker M, Wareham J (2012) Neonatal presentation of lethal neuromuscular glycogen storage disease type IV. J Perinatol 32:810–813
Gorzelanny C, Poppelmann B, Pappelbaum K, Moerschbacher BM, Schneider SW (2010) Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation. Biomaterials 31:8556–8563
Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288–1292
Kanneganti M, Kamba A, Mizoguchi E (2012) Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol 5:1–9
Malaguarnera L (2006) Chitotriosidase: the yin and yang. Cell Mol Life Sci 63:3018–3029
Michelakakis H, Dimitriou E, Labadaridis I (2004) The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update. J Inherit Metab Dis 27:705–706
Orchard PJ, Lund T, Miller W et al (2011) Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy. J Neuroinflammation 8:144
Ozen H (2007) Glycogen storage diseases: new perspectives. World J Gastroenterol 13:2541–2553
Sheth JJ, Sheth FJ, Oza NJ, Gambhir PS, Dave UP, Shah RC (2010) Plasma chitotriosidase activity in children with lysosomal storage disorders. Indian J Pediatr 77:203–205
Tumer L, Kasapkara CS, Biberoglu G, Ezgu F, Hasanoglu A (2013) Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity? J Pediatr Endocrinol Metab 26:1149–1152
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Jean-Marie Saudubray
Appendices
Take Home Message
Elevation of chitotriosidase activity is not only determined in lysosomal storage diseases but also in other macrophage activation-related conditions such as glycogen storage diseases.
Compliance with Ethics Guidelines
Conflict of Interest
Hayriye Hizarcioglu-Gulsen, Aysel Yuce, Zuhal Akcoren, Burcu Berberoglu-Ates, Yusuf Aydemir, Erdal Sag, and Serdar Ceylaner declare that they have no conflict of interest.
Informed Consent
An informed consent was obtained from the parents of the patient.
Animal Rights
This article does not contain any studies with animal subjects performed by the any of the authors.
Details of the Contributions of Individual Authors
Hayriye Hizarcioglu-Gulsen is the corresponding author. The draft of the manuscript was prepared and written by her and she is the guarantor for this report.
Aysel Yuce also participated in designation of the case report and revised it critically.
Zuhal Akcoren was responsible for histological assessment.
Burcu Berberoglu-Ates, Yusuf Aydemir, and Erdal Sag were responsible for clinical follow-up of the patient and they also participated in the drafting the manuscript.
Serdar Ceylaner performed the genetic analysis of the GBE1 gene.
Rights and permissions
Copyright information
© 2014 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hizarcioglu-Gulsen, H. et al. (2014). A Rare Cause of Elevated Chitotriosidase Activity: Glycogen Storage Disease Type IV. In: Zschocke, J., Gibson, K., Brown, G., Morava, E., Peters, V. (eds) JIMD Reports, Volume 17. JIMD Reports, vol 17. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2014_335
Download citation
DOI: https://doi.org/10.1007/8904_2014_335
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44577-8
Online ISBN: 978-3-662-44578-5
eBook Packages: MedicineMedicine (R0)